via: news92fm.com Patients who have been diagnosed with HER2-positive breast cancer may be eligible for a clinical study led by Baylor College of Medicine. The multi-institutional research will evaluate a new method of treatment that combines HER2-targeted therapies and excludes chemotherapy. The study is a follow-up to a recent clinical trial that showed HER2-positive breast […]